🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Amla extract
250 mg
25 mg
📊 Market median: 100.0mg (70 products)
Median 100.0mg This product: 25mg

Other Ingredients

Microcrystalline Cellulose Gelatin Dicalcium Phosphate Magnesium Stearate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (81% of products) Nutrient (6% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Doctor’s Suggested Use: Take 2 capsules daily - 1 capsule with morning meal and 1 capsule before going to bed.

⚠️ Warnings & Precautions

Precautions: Consult a health care practitioner before use if you take warfarin or other blood thinning products, or are pregnant or nursing, have a serious medical condition, or use any medications.

Keep out of reach of children.

Contains: Soy

🧪 Formulation Notes

Unconditionally guaranteed for purity and labeled potency.

Each capsule provides 1,000 FU (fibrin units) of nattokinase activity.

Clinically validated AmlaMax + NSK-SD40

Cardio health Blood pressure Cholesterol support Blood flow

GF Gluten Free

Additional Information

Almost out? Call 1-800-888-1415 or visit healthydirections.com Choose refill & save and never run out!

Store bottle with cap tightly closed in a cool, dry place.

GF Gluten Free

Product Details

UPC / SKU 6 78829 24145 6
DSLD Entry Date 2023-06-22
Product Type Other Combinations
Form Capsule
DSLD ID 287849
Data Updated 2026-04-11

Research Evidence

4 Research Sources
45 Avg Quality Score
2 Rct
1 Other
1 Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017
View all evidence for Nattokinase →

Compare Similar Products

View all Nattokinase products →